PharmaTimesNews & Politicsnews

Racura treats first patient in phase 1 HARNESS‑1 lung cancer trial

Thursday, June 25, 2026John PinchingView original

No adverse events observed as study begins in EGFR‑mutant NSCLC

Read the full article on the original site.

Read Full Article